New weapons in the war on malaria : halting the disease is crucial to improving overall health in Tanzania by Dale, Stephen
A plastic bag hangs from the ceiling of a village clinic in
Morogoro, Tanzania, where mothers and babies wait patiently
for treatment. Inside the bag is a large colourful net. The picture
on the bag shows an enormous mosquito held at bay by the
symmetrical grid of a mosquito net. A few feet away, tacked up
on a wooden door, a bright yellow poster depicts a warrior  —
shield and spear extended  —  ready to repel malaria-carrying
mosquitoes. Still another poster shows a smiling mother and
baby resting securely against the warrior’s shield. The unmistak-
able message of all these images? That insecticide-treated nets
(ITNs) provide vital protection against the mosquitoes that carry
malaria. That message is being heard throughout Tanzania. As
the message spreads, treated bednets are becoming increasingly
common. 
More than an illustration of the rising acceptance of ITNs, those
posters are proof of the new prominence antimalaria efforts
have acquired as health officials struggle to reduce Tanzania’s
high levels of mortality. The fight against malaria is proceeding
on many fronts, from preventative measures such as the promo-
tion of ITNs, to the introduction of more effective treatments,
such as new drug therapies.
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New Weapons in the War on Malaria
Halting the disease is crucial to improving overall health in Tanzania
Evidence showing the large impact of malaria on Tanzanians’ health has provided
the impetus for significant policy changes on how to treat and prevent the
disease across the country. The fight against malaria is now proceeding on many
fronts, from preventative measures such as the promotion of insecticide-treated
bednets to the introduction of more effective treatments, such as new drug
therapies. 
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Combating a major killer
This multipronged effort comes in response to the realiza-
tion of the high toll malaria takes on the health and well-
being of Tanzanians. Statistics compiled by the Tanzania
Essential Health Interventions Project (TEHIP) show that
malaria accounts for roughly 30% of the country’s burden
of disease (BOD). In some districts, such as Morogoro, it is
the largest single contributor to loss of life. Even those
who survive can pay a heavy price, with recurrent bouts of
debilitating illness.
This, in turn, has a large economic impact in countries
where malaria is endemic. A recent study by the Centre for
International Development at Harvard University and the
London School of Hygiene and Tropical Medicine suggests
that malaria-prone countries pay an economic “growth
penalty” as high as 1.3 percentage points per year, with
the cumulative effect that — when the loss is compounded
over 15 years — the gross national product of those coun-
tries can be reduced by nearly 20%. 
TEHIP — a joint project of the Tanzanian Ministry of Health
and Canada’s International Development Research Centre
(IDRC) — contributed to this new focus on malaria. By
developing a series of computer-based planning tools,
TEHIP made it possible for District Health Management
Teams (DHMTs) in two highly populated Tanzanian districts
to weigh their budget commitments and priorities against
the local BOD. The research showed that malaria
accounted for 30% of the years of life lost to death and
disease in the  two regions. Yet, in 1996, only 5% of health
budgets went toward malaria treatment and prevention.
Today this has changed: spending on malaria has increased
to 25% of the health budget. 
In the test districts of Rufiji and Morogoro, DHMTs redi-
rected funding priorities toward two large but previously
under-supported problems: malaria and a cluster of child-
hood ailments that could be addressed collectively by a
system of treatment known as the Integrated Management
of Childhood Illness (IMCI). At the national level, the pres-
entation of data showing the large impact of malaria on
Tanzanians’ health provided the impetus for significant
policy changes on how to treat and prevent the disease
across the country. 
The two test districts’ new focus on malaria and IMCI were
mutually reinforcing. TEHIP Project Coordinator Dr Harun
Kasale recalls that it was the districts’ inability to effec-
tively implement IMCI without changes to the standard
procedure for treating malaria that led TEHIP to lobby the
Ministry for a new antimalaria drug policy. Malaria, he
recounts, was one of that interlocking group of childhood
illnesses that IMCI was designed to address. Yet since
chloroquine, the standard drug for treating malaria, had
lost much of its effectiveness as the malaria parasite has
grown increasingly resistant to the drug, IMCI could not
significantly improve children’s health until a better
remedy was found. 
A need for effective treatment
“We reported to the Ministry that IMCI would not work if
we continued working with the wrong drug, chloroquine,
because the research showed that resistance ranges from
50% to 70%,” says Dr Kasale. “If you look at data from the
surveillance, it showed that children suffering from malaria
did attend the clinic, but they still died. That’s because they
were getting the wrong medicine. The Ministry did allow
the districts to change to new drugs, and that meant that
IMCI became a viable intervention using viable drugs —
using credible, effective drugs.” 
At first it was decided to replace choroquine with alterna-
tive drugs that would comprise three new tiers of treat-
ment. The first-line drug for treating malaria would be
sulfadoxine-pyrimethamine (SP), with amodiaquine (AQ) as
the second line, and quinine as the third line (although
quinine would be the first-line drug in severe cases). The
problem that remained, however, was that resistance was
already being observed with these new drugs: SP’s treat-
ment failure was calculated at 9.5%, and AQ’s treatment
failure was 4.6%. 
It was therefore suggested to get ready to move to “com-
bination therapy” (CT) in which malaria patients would be
prescribed a course of pills containing more than one anti-
malaria medicine. The advantage of CT to the patient is
that if one drug fails, the other one takes over. More
generally, it is believed that CT can slow the progression 
of drug resistance in malaria parasites. This resistance
generally develops when a malaria parasite that is partially
resistant to a drug survives long enough to reproduce.
With combination therapy, however, the second drug kills
the malaria parasite before it has an opportunity to pass
on its genetic material, thus interrupting the process of
selection of resistant strains. 
A powerful demonstration effect
According to Dr Kasale, introducing more effective
approaches for managing malaria has bolstered the
public’s confidence that the health system can deal with
the disease. For instance, many mothers whose children
suffered from late stage malaria with convulsions were
reluctant to have those children treated in a health facility.
Although malaria with convulsions is very dangerous —
likely to lead to death — the condition, known in Tanzania
as ndegedege, is often not associated with malaria, but to
the presence of spirits or changes in the weather. These
parents were more likely to consult traditional healers. This
was reinforced by the fact that health practitioners con-
ventionally gave the child an injection to treat the convul-
sions. “The parents also believed that if that child got an
injection [to treat convulsions], that was a ticket for that
child to die,” says Dr Kasale.
To assuage parents’ fears, practitioners in community
health facilities opted for a new form of treatment to stop
the convulsions: they mixed valium with water and admin-
istered the solution rectally. “Within a minute the child is
better,” says Dr Kasale, adding that the child who is no
longer convulsing can then be treated with oral anti-
malarial drugs and transferred to a larger health centre 
for treatment. 
This nearly instant recovery from convulsions had a miracu-
lous impact on the public perception of the health system.
“The health worker gave the child this treatment in front
of the rest of the mothers,” continues Dr Kasale. “After
seeing the child recover without an injection, they were
amazed. So the word went around, and mothers started
bringing these children to the health facilities.” Dr Kasale
believes that this demonstration effect — patients seeing
the beneficial results and then telling others about
them — is one reason that attendance at clinics in Rufji
and Morogoro has risen dramatically. 
The efficacy of treated nets
Better treatment, however, is only half of the struggle
against malaria. Policymakers and practitioners know that
making inroads against this devastating disease also
requires an effective prevention program. The main tool:
insecticide-treated bednets.
According to Dr Kasale, communities have long understood
that there are advantages to being shielded from mosquito
bites. In Rufiji, for instance, many households used tradi-
tional woven grass sleeping bags to protect against
mosquito bites. But while untreated nets and traditional
barriers can reduce the nuisance factor associated with
mosquitoes, they have their limitations. Mosquitoes can
enter the net if it is torn or hung badly, and can bite any
part of the body in contact with the net. 
By contrast, nets treated with pyrethroid insecticides (ITNs)
provide much more than a physical barrier; they actually
kill or deter mosquitoes from feeding and drive them from
their hiding places. Even a treated net with large holes in
it provides as much protection as an intact one, reducing
mosquito bites by up to 95%. Mosquitoes are killed by the
insecticide before they can find a place to bite through the
net or push through a hole. The Ifakara Health Research
and Development Centre has determined that ITNs could
avert 30 000 deaths and more than 5 million clinical
episodes of malaria annually in Tanzania.
Research results summarized in Net Gain: A New Method
for Preventing Malaria Deaths1, a copublication of IDRC
and the World Health Organization, indicate that ITNs
could reduce child mortality by at least 17%. The benefits
of using treated nets also accrue to the entire community.
Recent evidence shows that a high-concentration of
treated nets in a community will afford some protection to
all people in the area, even those who do not own a bed-
net themselves.
Not surprisingly, promoting the use of ITNs has become a
key weapon in health officials’ battle against malaria.
Because the high cost of the early treated nets  —  about
US $10 for a family-sized net  —  discouraged many people
from purchasing them, the nets were promoted through a
social marketing campaign in Tanzania, led by Population
Services International, a nongovernmental organization,
with support from the UK Department for International
Development. These efforts proved effective at enhancing
awareness of the benefits of ITNs, dramatically decreasing
the cost of nets and increasing their use.
Today, the nets are widely available. As their popularity
spread, the cost declined to about US $4 and public health
officials have turned their attention to those at highest risk
from malaria  —  pregnant women and young children.
The goal: to see 60% of children and pregnant women
protected by a net by 2005. In the next phase of the
national ITN strategy, every pregnant woman who visits a
health centre will receive a voucher for a bednet. She can
redeem the voucher for an ITN by visiting a private vendor.
In turn, the vendor will be reimbursed after bringing the
voucher to an authorized government agent.
Delivering multiple benefits
The voucher system is expected to bring multiple benefits.
First, it transfers responsibility for procuring and distribut-
ing the nets away from overburdened community health
workers to private manufacturers, wholesalers, retailers,
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Making inroads against this devastating disease
requires an effective prevention program. The main
tool: insecticide-treated bednets.
1 Net Gain: A New Method for Preventing Malaria Deaths,
edited by Christian Lengeler, Jacqueline Cattani, and Don de
Savigny. IDRC 1996, ISBN 0-88936-792-2; 260 pp.
http://web.idrc.ca/en/ev-9338-201-1-DO_TOPIC.html
and distributors. Second, it focuses on a particularly vulnerable
group: pregnant women and young children. Research has shown
that women infected with malaria during pregnancy are highly
likely to deliver low birth weight babies. As well, infants quickly
lose the immunity they may have acquired passively from their
mothers. This makes them highly susceptible to malaria and a
range of secondary conditions (anemia, malnutrition, febrile
seizures, sudden cardiac arrest, and a general failure to thrive,
among others) that are a direct result of malaria.
The voucher system also entices women who may not otherwise
receive care to establish a relationship with a health facility.
Offering a pregnant woman a voucher for an ITN —  an item of
significant value — is a powerful incentive for her to visit a clinic
where she can receive antenatal care. The baby can also be immu-
nized and mother and child can receive follow-up health care. 
This is just one of the many ways in which more effective and
integrated initiatives against malaria have become a cornerstone
of broader efforts to revitalize Tanzania’s health system. 




More information on the capacity building of District Health Management teams
in Morogoro and Rufiji can be found in Fixing Health Systems, by Don de
Savigny, Harun Kasale, Conrad Mbuya, and Graham Reid. The book describes the
Tanzania Essential Health Interventions Project – its origins, impact, important
lessons, observations, and recommendations for decision-makers and policy ana-
lysts. The full text of the book is available on a thematic Web dossier, which leads
the reader into a virtual web of resources that explores the TEHIP story:
www.idrc.ca/tehip. 
More information on malaria control can be found at:
http://www.rbm.who.int/
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Public health officials have turned their attention to
those at highest risk from malaria  —  pregnant
women and young children. 
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